Press Releases

Photo of Dr Jan Kölemen standing in front of his scientific poster at the ESC Congress, titled "From evidence to practice: Mavacamten in obstructive Hypertrophic Cardiomyopathy – data from the multicenter TORCH-Plus-DZHK21". He is wearing glasses, a dark suit, light blue tie, and an ESC Congress lanyard with name badge, smiling at the camera.

How does a new medicine perform once it is used in everyday clinical practice after approval? This is the question being investigated jointly by the…

Group photo of the TRIC-I-HF study team standing in front of a DZHK (German Centre for Cardiovascular Research) sign at the Munich site, in white lab coats: three men at the back and one woman wearing a green lanyard in the front centre.

Study by the German Centre for Cardiovascular Research (DZHK), led by LMU University Hospital Munich, demonstrates for the first time benefits in hard…

Portrait photo of a man with curly, dark blond hair and a beard, wearing a blue-and-white checked shirt and a grey blazer, smiling at the camera against a neutral light grey background.

Heidelberg-based biotech company REVIER Therapeutics has officially launched. The company, which emerged from research conducted at the German Centre…

Illustration of a blood vessel with flowing red blood cells and deposits along the vessel wall, overlaid with a large, semi-transparent cannabis leaf.

The so-called cannabinoid receptor was originally discovered because active compounds from the cannabis plant bind to it. In fact, however, it belongs…

Cross-section of a blood vessel with atherosclerotic plaque severely narrowing the vessel lumen.

A spatial analysis of proteins in human blood vessels shows why some deposits tear more easily. A team from the DZHK site in Munich reports on this in…

A close-up of a person wearing a light grey shirt, holding a small white medicine bottle and pouring tablets into their open hand.

An analysis of the DECLARE-TIMI 58 trial shows that carriers of cardiomyopathy-related genes benefit disproportionately from dapagliflozin. The…

Close-up of a gloved hand using tweezers to handle a tissue sample in a laboratory multiwell plate

The German Centre for Cardiovascular Research (DZHK) has published an open call for the funding of innovative translational research projects.

A man (Prof. Dr Steffen Massberg) is standing in a corridor wearing a lab coat and looking friendly at the camera.

The German Research Foundation (DFG) is establishing new Collaborative Research Centres and extending existing research networks. Several DZHK sites…

Highly magnified, electron microscope image of numerous red blood cells showing their characteristic biconcave, disc-shaped form.

Red blood cells have a greater influence on the function of blood vessels than previously thought. Researchers at the DZHK’s RheinMain site have shown…

Illustration showing a DNA double helix, a gene-editing scissor symbol and a stylised heart with a glowing red point, alongside the text "Nature Cardiovascular Research (2026)" and a circular portrait photo of Maarten M. G. van den Hoogenhof

A study conducted by the Heidelberg/Mannheim site of the German Centre for Cardiovascular Research (DZHK) has identified the overactivity of CaMKIIδ…

Press releases

DZHK registry shows how new therapies perform in routine clinical care

Minimally Invasive Tricuspid Valve Repair Reduces Mortality and Hospitalisations

From Cardiovascular Research to a Biotech Company: REVIER Therapeutics Launches with €6 Million

Cannabinoid receptor identified as new target against atherosclerosis

Why some plaques become dangerous

SGLT2 inhibitor effectively protects against heart failure in individuals with genetic risk

DZHK Launches Open Call for Translational Research Funding

Funding for three Collaborative Research Centres at DZHK sites

Higher levels of nitric oxide do not automatically mean better vascular function

Genetic heart failure: a new target for cause-based therapy